I agree that this site is using cookies. You can find further informations here.
X
Rozeman, E A
49  results:
Search for persons X
?
1

Survival and biomarker analyses from the OpACIN-neo and OpA..:

Rozeman, E. A. ; Hoefsmit, E. P. ; Reijers, I. L. M....
Nature Medicine.  27 (2021)  2 - p. 256-263 , 2021
Link: https://doi.org/10.1038/..
 
?
2

Health-related quality of life of long-term advanced melano..:

Boekhout, A. H. ; Rogiers, A. ; Jozwiak, K....
Acta Oncologica.  60 (2020)  1 - p. 69-77 , 2020
Link: https://doi.org/10.1080/..
 
?
3

Surgical removal of the index node marked using magnetic se..:

Schermers, B ; Franke, V ; Rozeman, E A...
British Journal of Surgery.  106 (2019)  5 - p. 519-522 , 2019
Link: https://doi.org/10.1002/..
 
?
4

Predicting response to cancer immunotherapy using noninvasi..:

Trebeschi, S. ; Drago, S.G. ; Birkbak, N.J....
Annals of Oncology.  30 (2019)  6 - p. 998-1004 , 2019
Link: https://doi.org/10.1093/..
 
?
5

PO-512 Gene expression signature comprising distinct stroma..:

Krijgsman, O. ; Kemper, K. ; Rozeman, E....
ESMO Open.  3 (2018)  - p. A223 , 2018
Link: https://doi.org/10.1136/..
 
?
6

Correlation between symptoms, endoscopic features and treat..:

Geukes Foppen, M. ; Rozeman, E. ; Van Wilpe, S....
European Journal of Cancer.  72 (2017)  - p. S159 , 2017
Link: https://doi.org/10.1016/..
 
?
7

Pharmacogenetic variants associated with outcome in patient..:

Meulendijks, D ; Rozeman, E A ; Cats, A...
The Pharmacogenomics Journal.  17 (2016)  5 - p. 441-451 , 2016
Link: https://doi.org/10.1038/..
 
?
8

Neoadjuvant Cytoreductive Treatment of Regionally Advanced ..:

Madu, Max F. ; Rozeman, E.A. Lisette ; van der Hage, Jos A....
Clinical Skin Cancer.  1 (2016)  1 - p. 48-52 , 2016
Link: https://doi.org/10.1016/..
 
?
9

Health-related quality of life of long-term advanced melano..:

Boekhout, A. H ; Rogiers, A ; Jozwiak, K...
Boekhout , A H , Rogiers , A , Jozwiak , K , Boers-Sonderen , M J , van den Eertwegh , A J , Hospers , G A , de Groot , J W B , Aarts , M J B , Kapiteijn , E , ten Tije , A J , Piersma , D , Vreugdenhil , G , van der Veldt , A A , Suijkerbuijk , K P M , Rozeman , E A , Neyns , B , Janssen , K J , van de Poll-franse , L V & Blank , C U 2021 , ' Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls ' , Acta Oncologica , vol. 60 , no. 1 , pp. 69-77 . https://doi.org/10.1080/0284186X.2020.1818823.  , 2021
Link: https://cris.maastrichtu..
 
?
10

Health-related quality of life of long-term advanced melano..:

Boekhout, A. H ; Rogiers, A ; Jozwiak, K...
Boekhout , A H , Rogiers , A , Jozwiak , K , Boers-Sonderen , M J , van den Eertwegh , A J , Hospers , G A , de Groot , J W B , Aarts , M J B , Kapiteijn , E , ten Tije , A J , Piersma , D , Vreugdenhil , G , van der Veldt , A A , Suijkerbuijk , K P M , Rozeman , E A , Neyns , B , Janssen , K J , van de Poll-Franse , L V & Blank , C U 2021 , ' Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls ' , Acta Oncologica , vol. 60 , no. 1 , pp. 69-77 . https://doi.org/10.1080/0284186X.2020.1818823.  , 2021
Link: https://research.vumc.nl..
 
?
11

Health-related quality of life of long-term advanced melano..:

Boekhout, A H ; Rogiers, A ; Jozwiak, K...
https://research.rug.nl/en/publications/2fd1c608-cbe4-4d9f-bfab-951717657a8b.  , 2021
Link: https://hdl.handle.net/1..
 
?
12

Pathological response and tumour bed histopathological feat..:

Rawson, R. V ; Adhikari, C ; Bierman, C...
Rawson , R V , Adhikari , C , Bierman , C , Lo , S N , Shklovskaya , E , Rozeman , E A , Menzies , A M , van Akkooi , A C J , Shannon , K F , Gonzalez , M , Guminski , A D , Tetzlaff , M T , Stretch , J R , Eriksson , H , van Thienen , J V , Wouters , M W , Haanen , J B A G , Klop , W M C , Zuur , C L , van Houdt , W J , Nieweg , O E , Ch'ng , S , Rizos , H , Saw , R P M , Spillane , A J , Wilmott , J S , Blank , C U , Long , G V , van de Wiel , B A & Scolyer , R A 2021 , ' Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma ' , Annals of Oncology , vol. 32 , no. 6 , pp. 766-777 . https://doi.org/10.1016/j.annonc.2021.03.006.  , 2021
Link: https://researchers.mq.e..
 
?
13

Discontinuation of anti-PD-1 antibody therapy in the absenc..:

Jansen, Y. J. L ; Rozeman, E. A ; Mason, R...
10.1093/annonc/mdz110.  , 2020
Link: http://hdl.handle.net/10..
 
?
14

Predicting response to cancer immunotherapy using noninvasi..:

Trebeschi, S ; Drago, S. G ; Birkbak, N. J...
https://pure.au.dk/portal/en/publications/0c30ab7d-81f4-44f7-b42a-0bb89f9a023e.  , 2019
Link: https://pure.au.dk/porta..
 
?
15

Predicting response to cancer immunotherapy using noninvasi..:

Trebeschi, S ; Drago, S G ; Birkbak, N J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594459/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
1-15